- Home
- TOVX vs PRSO Comparison
TOVX vs PRSO Comparison
Compare TOVX & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- PRSO
- Stock Information
- Founded
- TOVX 2001
- PRSO 2008
- Country
- TOVX United States
- PRSO United States
- Employees
- TOVX N/A
- PRSO N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- TOVX Health Care
- PRSO Technology
- Exchange
- TOVX Nasdaq
- PRSO Nasdaq
- Market Cap
- TOVX 4.5M
- PRSO 4.3M
- IPO Year
- TOVX 2006
- PRSO 2001
- Fundamental
- Price
- TOVX $0.43
- PRSO $0.83
- Analyst Decision
- TOVX Hold
- PRSO Strong Buy
- Analyst Count
- TOVX 1
- PRSO 1
- Target Price
- TOVX N/A
- PRSO $3.00
- AVG Volume (30 Days)
- TOVX 371.0K
- PRSO 224.1K
- Earning Date
- TOVX 08-12-2025
- PRSO 08-11-2025
- Dividend Yield
- TOVX N/A
- PRSO N/A
- EPS Growth
- TOVX N/A
- PRSO N/A
- EPS
- TOVX N/A
- PRSO N/A
- Revenue
- TOVX N/A
- PRSO $15,626,000.00
- Revenue This Year
- TOVX N/A
- PRSO $0.69
- Revenue Next Year
- TOVX N/A
- PRSO $35.21
- P/E Ratio
- TOVX N/A
- PRSO N/A
- Revenue Growth
- TOVX N/A
- PRSO 35.50
- 52 Week Low
- TOVX $0.40
- PRSO $0.52
- 52 Week High
- TOVX $7.15
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- TOVX 39.54
- PRSO 32.77
- Support Level
- TOVX $0.45
- PRSO $0.95
- Resistance Level
- TOVX $0.49
- PRSO $1.04
- Average True Range (ATR)
- TOVX 0.04
- PRSO 0.06
- MACD
- TOVX -0.00
- PRSO -0.02
- Stochastic Oscillator
- TOVX 17.79
- PRSO 12.05
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.